This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A third opinion: Discussing the potential of Vaxcyte's 24-Valent Pneumococcal Conjugate Vaccine Candidate for the Prevention of Invasive Pneumococcal Disease in Adults Aged 18-64
Ticker(s): PCVXWho's the expert?
Institution: MDFMR and Healis Health
- Board certified family physician and geriatrician in Central Maine.
- faculty appointment at the Geisel Dartmouth School of Medicine and University of New England
- Caring for patients for over 30 years.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
